BioCryst Pharmaceuticals, Inc. (BCRX)
Nasdaq: BCRX · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 1995
Grade6.1
◀ Past 6.3● Present 5.6▶ Future 6.4
Who owns BioCryst Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
5
Blackrock, Inc. holds 8.4% of Common Stock, as its SCHEDULE 13G/A filed Apr 17, 2025 says.
Directors and officers
14
report now, of 31 people on the record since 2007. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Common Stock
Deerfield Mgmt, L.P.
SCHEDULE 13G/A · filed Feb 12, 2026 · Common Stock · 5.8% in Sep 19, 2025
RA Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value per share · 7.3% in Nov 12, 2025
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK · 4.9% in May 12, 2026
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Avoro Capital Advisors LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.01 par value · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What BCRX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Astria
An entity · legal entity · owns, named in the 10-K filed Feb 26, 2026
7 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
10sales
0purchases
8sales on a scheduled plan
4people selling
$4.1Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 35 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Barnes Alane P | Chief Legal Officer | 7 | $3.5M | 7 | 0 | $0 |
| Heggie Theresa | director | 1 | $500,000 | 0 | 0 | $0 |
| Mckee Amy E | director | 1 | $100,000 | 0 | 0 | $0 |
| Sanders Machelle | director | 1 | $100,000 | 1 | 0 | $0 |